What researchers published on Diffúz nagy B-sejtes limfóma (DLBCL)
13 685 papers, newest first.
Showing 140 of 13 685
Primary testicular diffuse large B-cell lymphoma: recent advances in pathobiology and management.Current opinion in oncology
Unanswered Question Regarding CNS Prophylaxis in CD5-Positive Diffuse Large B-Cell Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
EsetismertetésNeurological Masquerades of Diffuse Large B-cell Lymphoma: A Case Mimicking Motor Neurone Disease.Cureus
[A case of anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) complicating diffuse large B-cell lymphoma (DLBCL)].Rinsho shinkeigaku = Clinical neurology
Reply to: Unanswered Question Regarding CNS Prophylaxis in CD5-Positive Diffuse Large B-Cell Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ÁttekintésImmunotherapies and Chemo-Sparing Approaches: A New Era for Diffuse Large B-Cell Lymphoma in Older Patients.Cancers
Prognostic analysis of HALP -LDH composite model in newly diagnosed diffuse large B-cell lymphoma patients.Frontiers in physiology
Real-world access and barriers to CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a population-based study.Transplantation and cellular therapy
Spatial topology on baseline PET/CT improves risk stratification in disseminated diffuse large B-cell lymphoma: a multicenter study.Cancer imaging : the official publication of the International Cancer Imaging Society
EsetismertetésSuccessful salvage therapy with glofitamab followed by selinexor maintenance in an elderly patient with primary refractory diffuse large b-cell lymphoma harboring TP53 and CD58 mutations: a case report and literature review.Frontiers in oncology
LILRB1 as a novel therapeutic target for CAR-T therapy in diffuse large B cell lymphoma.Molecular therapy : the journal of the American Society of Gene Therapy
Targeting CCR7 Attenuates Aggressive Phenotypes in Diffuse Large B-Cell Lymphoma by Suppressing Wnt/β-Catenin Signaling.Cancer medicine
Discovery of Tricyclic Oxazinoquinolinone-Based BCL6 PROTAC Degraders with Potent Activity Against Diffuse Large B-Cell Lymphoma.Journal of medicinal chemistry
Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation.Proceedings of the National Academy of Sciences of the United States of America
Clinical characteristics and prognosis analysis of secondary intestinal diffuse large B-cell lymphoma: a multi-center retrospective study over a decade.Frontiers in oncology
Integrative transcriptomic and in silico analysis identifies novel long non-coding RNAs associated with BCL6 and SPARC in diffuse large B-cell lymphoma.Computational biology and chemistry
[Mitoxantrone hydrochloride liposomes combined with R-GDP regimen in the treatment of relapsed/refractory diffuse large B-cell lymphoma: a single-arm, multicenter, exploratory clinical study].Zhonghua zhong liu za zhi [Chinese journal of oncology]
Orbital Diffuse Large B-Cell Lymphoma Masquerading as Periorbital Cellulitis in a Paediatric Patient With Ataxia-Telangiectasia: A Case Report.Case reports in oncological medicine
Multiple and central nervous system extranodal involvement predict poor prognosis in R/R DLBCL following CD19 CAR-T therapy.Leukemia research
EsetismertetésIntravascular large B-cell lymphoma presenting as unilateral lymphedema in a patient with rheumatoid arthritis and sarcoidosis: A case report.Medicine
Orelabrutinib plus R-CHOP in patients with newly diagnosed non-GCB double-expressor DLBCL: A single-arm, phase II study.British journal of haematology
An immunogenic cell death related signature links efferocytosis to immunosuppression and therapeutic vulnerabilities in DLBCL.BMC immunology
EsetismertetésDiffuse Large B-Cell Lymphoma Presenting as Clinically Isolated Massive Splenic Disease: A Case Report.Cureus
Dynamic prognostic stratification and survival prediction in elderly patients with diffuse large B-cell lymphoma: a real-world evidence study.BMC cancer
EsetismertetésIntermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report.Journal of medical case reports
Áttekintés[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO.Clinical lymphoma, myeloma & leukemia
Temporal clinical trajectories and Day+14 landmark stratification of infection risk after CD19 CAR T-cell therapy.Frontiers in cellular and infection microbiology
Diffuse Large B-Cell Lymphoma Presenting as a Rapidly Enlarging Forehead Mass Initially Suggestive of a Subgaleal Hematoma: A Case Report.Clinical case reports
EsetismertetésDiffuse Large B-cell Lymphoma With Tumor Thrombus in the Superior Mesenteric Vein: A Case Report.Cureus
Hypoxia-induced NETs establish a self-reinforcing immunosuppressive circuit that can be targeted to enhance immunotherapy in DLBCL.Journal of translational medicine
Correction: Deceptive initial presentation of systemic DLBCL with CNS progression following oligometabolic PET/CT: case report.Frontiers in oncology
EsetismertetésPrimary Cervical Diffuse Large B-cell Lymphoma Incidentally Diagnosed During Evaluation of High-Grade Cervical Dysplasia: A Case Report.Cureus
Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024-2028.Leukemia & lymphoma
Expression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes.BMC medical genomics
Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.Blood cancer journal
Esetismertetés[Cardiac Malignant Lymphoma with Right Atrial Occlusion Responding to Tumor Resection and Postoperative Chemotherapy:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
Efficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study.Frontiers in oncology
EsetismertetésLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
Generation and multidimensional profiling of a rituximab-resistant ABC-type diffuse large B-cell lymphoma cell line.Epigenomics
The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma.Leukemia
ÁttekintésProgression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?Expert review of hematology
Baseline Spleen Volume is Independently Associated With Survival After CD19-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.Hematological oncology
EsetismertetésEpcoritamab achieves durable remission after CD20 antigen escape in primary cardiac diffuse large B-cell lymphoma.Annals of hematology
Áttekintés[Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].Zhonghua bing li xue za zhi = Chinese journal of pathology
Central and peripheral Neurolymphomatosis, a rare involvement of DLBCL on PET/CT.EJNMMI reports
A temporal coupling hypothesis for chemoresistance in canine DLBCL and osteosarcoma: stress signalling and microRNA regulation.Veterinary and animal science
Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025;9(10):2489-2499.Blood advances
EsetismertetésPrimary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, With Rapid Systemic Progression in an Elderly Patient: A Case Report.Cureus
Economic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis.Cost effectiveness and resource allocation : C/E
EsetismertetésWhen lymphoma masquerades as carcinoma: A rare case of primary nasopharyngeal diffuse large B-cell lymphoma with aberrant p63 expression.Indian journal of pathology & microbiology
A Rare Case of Hypoglossal Nerve Neurolymphomatosis in a Patient Treated With Diffuse Large B-Cell Lymphoma.EJHaem
Plasma metabolomics and ctDNA analysis in newly diagnosed diffuse large B-cell lymphoma: an exploratory study.Blood advances
Real-world outcomes of glofitamab monotherapy in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma: A multicenter Korean cohort.Annals of hematology
Beta-blocker use and survival in diffuse large B-cell lymphoma: a post hoc analysis of the RICOVER-60 trial.Haematologica
Sintilimab plus R-CHOP versus DA-EPOCH-R as first-line therapy for primary mediastinal large B-cell lymphoma: a real-world comparative cohort study.Frontiers in immunology
Primary Prostatic Diffuse Large B-Cell Lymphoma Mimicking Prostate Cancer With a Normal Prostate-Specific Antigen Level.IJU case reports
Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications.Arthritis research & therapy
ÁttekintésRole of PET/CT in diffuse large B-cell lymphoma (Review).Molecular and clinical oncology
An Exploratory Study of Fusion of Intratumoral and Peritumoral Ultrasound Radiomics With Clinical Features for Distinguishing Diffuse Large B-Cell Lymphoma From Hodgkin Lymphoma.Ultrasound in medicine & biology
Áttekintés[Current treatment strategies for diffuse large B-cell lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
MIP-1α and MIP-1ß as Potential Contributors to Bone Lesion Formation in Diffuse Large B-cell Lymphoma: A Case Report.Internal medicine (Tokyo, Japan)
EsetismertetésMyocardial Infarction with Non-obstructive Coronary Arteries; Diffuse Large B-Cell Lymphoma Presenting as an Acute Coronary Syndrome.Archives of academic emergency medicine
EsetismertetésPrimary renal diffuse large B cell lymphoma misdiagnosed as renal cell carcinoma: A case report.Medicine
Distinct clinical associations of baseline and treatment-emergent hypogammaglobulinemia in diffuse large B-cell lymphoma: a retrospective real-world cohort study.Annals of hematology
Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.Biomedicines
EsetismertetésPersistent Type B Hyperlactataemia as a Diagnostic Clue to Occult Diffuse Large B-cell Lymphoma-Associated Haemophagocytic Lymphohistiocytosis.Cureus
EsetismertetésIntestinal Mature B-Cell Non-Hodgkin Lymphoma Presenting as an Acute Surgical Abdomen in Children: A Case Series.Pediatric reports
Randomizált vizsgálatBaseline Tumor Transcriptional Features and Event-Free Survival After Anti-CD19 CAR T-Cell Therapy with Axicabtagene Ciloleucel in Large B-Cell Lymphoma: An Exploratory Reanalysis of the Randomized ZUMA-7 Trial.Medical sciences (Basel, Switzerland)
EsetismertetésCD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy.Cureus
EsetismertetésPlasmablastic non-Hodgkin's lymphoma: a case report and review of the literature.Journal of medical case reports
Prediction of Double-Expressor Lymphoma in Diffuse Large B-Cell Lymphoma Using a Non-invasive Model Based on [18F] FDG PET/CT and Stacking.Academic radiology
Randomizált vizsgálatZamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.The Lancet. Oncology
EsetismertetésAnti-Transcriptional Intermediary Factor 1 Gamma Antibody-Positive Dermatomyositis Concomitant with Diffuse Large B-Cell Lymphoma: Case Report and Literature Review.Case reports in oncology
PreprintPOU2AF2/OCA-T1 coactivates POU2F2 and defines a lineage-specific dependency in diffuse large B-cell lymphoma.bioRxiv : the preprint server for biology
Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.British journal of haematology
Associations of Subcutaneous and Visceral Fat Areas with Progression-Free Survival in Patients with Diffuse Large B-Cell Lymphoma.International journal of medical sciences
A public-data audit of transcriptomic prognostic transportability in R-CHOP-treated diffuse large B-cell lymphoma.PloS one
Second Primary Malignancy in Patients with DLBCL Receiving CAR T Therapy and Other Systemic Anticancer Therapy: Real-World Evidence from a Large US National Claims Database.Transplantation and cellular therapy
Outcomes of gastrointestinal bleeding events after first-line chemotherapy in gastrointestinal-diffuse large B-cell lymphoma: a propensity-score matched analysis.Annals of hematology
Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma.Leukemia research
Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma.Blood neoplasia
12-Month Disease-Free Survival Prediction in Diffuse Large B-Cell Lymphoma: A Multimodal Transfer Learning Innovation.Proceedings of SPIE--the International Society for Optical Engineering
CAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.British journal of haematology
Potential Role of BCL2 and BCL6 Overexpression in Circulating Tumor Cells as Molecular Biomarkers in DLBCL After R-CHOP Therapy.Revista medica de Chile
Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL.Annals of hematology
Exploring Potential Multi-Target Inhibition Mechanisms of Ganoderma lucidum Against EBV-Mediated DLBCL Using Integrative Bioinformatics, Machine Learning, and Network Pharmacology Approaches.Journal of food science
Favorable survival for older adults treated with Axi-cel and Tisa-cel CD19 CAR-T therapy for relapsed/refractory DLBCL: a U.S. multicenter comparative analysis.Transplantation and cellular therapy
Autologous hematopoietic stem cell transplantation in a patient with relapsed diffuse large B-cell lymphoma and type 3 von Willebrand disease: a case report.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Treatment patterns and outcomes for second-line therapy in large B-cell lymphoma: results from the LEO CReWE study.Blood cancer journal
EsetismertetésCavitary Lung Lesion as the Initial Presentation of Diffuse Large B-Cell Lymphoma: A Case Report With Review of the Literature.Cureus
Vizsgálati eredményEfficacy and safety of ifupinostat in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase 2 study.Signal transduction and targeted therapy
EsetismertetésNasopharyngeal diffuse large b-cell lymphoma in a teenage presenting with cavernous sinus syndrome: A case report.Radiology case reports
Transformation to Plasmablastic Lymphoma Following CD19-Directed CAR T Cell Therapy for Refractory Diffuse Large B Cell Lymphoma: A Case Report.Case reports in pathology
Continuous spatially informed microenvironment programs show cross-cohort concordance and context-dependent spatial organization in diffuse large B-cell lymphoma.Frontiers in oncology
ÁttekintésSpatial immune ecosystems and therapy resistance in large B-cell lymphoma: from single-cell multi-omics to immunotherapy-matched validation.Frontiers in immunology
Zanubrutinib monotherapy in CD79B-mutated relapsed or refractory diffuse large B-cell lymphoma: A multicenter Phase 2 study.HemaSphere
ÁttekintésA panoramic study of circulating tumor DNA in diffuse large B-cell lymphoma.Genes & diseases
Novel antibody-based regimens for large B-cell lymphoma: latest updates from the 2026 ASCO Annual Meeting.Journal of hematology & oncology
Analysis of Treatment Patterns and Outcomes Among Patients with Third-Line or Later (3L+) Diffuse Large B-Cell Lymphoma (DLBCL) with Multiple Qualifying Index Dates Treated in the United States.Journal of clinical medicine
lncRNA CHROMR promotes DLBCL viability and invasion in an m 6A-dependent manner.Acta biochimica et biophysica Sinica
EsetismertetésEosinophilic dermatosis of hematologic malignancy in a patient with diffuse large B-cell lymphoma: A diagnostic challenge.Actas dermo-sifiliograficas
ÁttekintésFrom Divergent Pathogenesis to Precision Medicine: The Road to Targeted Therapy in HIV-Associated and HIV-Unrelated Diffuse Large B-Cell Lymphoma.Diagnostics (Basel, Switzerland)
Loncastuximab and Rituximab in Elderly Unfit/Frail Patients With Previously Untreated Diffuse Large B-Cell Lymphoma.Blood advances
Recurrent Intermittent Small Bowel Obstruction as an Initial Manifestation of Primary Intestinal Diffuse Large B-Cell Lymphoma: A Case Report and Systematic Literature Review.Case reports in surgery
EsetismertetésCase Report: Epitheliotropic cutaneous presentation of multicentric diffuse large B-cell lymphoma in a dog.Frontiers in veterinary science
EsetismertetésDiffuse large B-cell lymphoma of the colon: surgical complexities in a rare tumor.Revista de gastroenterologia de Mexico (English)
Blood Cell Biophysical Trajectories Reveal Response to CAR-T Therapy in Diffuse Large B-Cell Lymphoma.ACS sensors
Long-term mental health service utilization among patients with diffuse large B-cell lymphoma: a population-based study.Leukemia & lymphoma
EsetismertetésPrimary bladder diffuse large B-cell lymphoma causing unilateral ureterovesical junction obstruction: A case report.Urology case reports
EsetismertetésFlow cytometry in the diagnosis and monitoring of lymphoma based on urine samples: a case report.Laboratory medicine
A Novel Plasma Biomarker hsa_circ_0080018 Drives DLBCL Progression via M2 Polarization of Tumor-Associated Macrophages.Cancer science
Long-term apremilast treatment in a patient with HIV infection, previous HBV/HCV infection, and subsequent diffuse large B-cell lymphoma.European journal of dermatology : EJD
The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL.Hematological oncology
EsetismertetésComplex Cardiac Tumor with Concomitant Pericardial Effusion and Hemodynamic Compromise in a Septuagenarian: Case Report of Anesthetic and Surgical Considerations.Annals of cardiac anaesthesia
CUE domain-containing 2 promotes diffuse large B-cell lymphoma progression via PP2A-B55β degradation and shapes macrophage-mediated immune responses.Molecular biomedicine
CD19 CAR T-cell Escape in Large B-cell Lymphoma: Antigen Density Matters after All.Blood cancer discovery
EsetismertetésScleroderma-Like Skin Changes and Multifocal Muscle Thickening in a Patient with Diffuse Large B-Cell Lymphoma: A Case Report.Cancer management and research
Accelerated Glofitamab as Urgent Bridging to CAR T-Cell Therapy in High-Risk Relapsed/Refractory Large B-Cell Lymphoma.Hematological oncology
Incidence rates of non-Hodgkin lymphoma subtypes among Black Africans with and without HIV in South Africa: a national registry-based study.The Lancet regional health. Africa
EsetismertetésPrimary CD5+ nongerminal center B-cell diffuse large B-cell lymphoma of the breast: A case report.JAAD case reports
EsetismertetésFibrous dysplasia of the jaw and diffuse large B-cell lymphoma coexistence, diagnosis and treatment experience and analysis: a case report.Frontiers in surgery
Retraction Note: Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target.Hereditas
ÁttekintésResistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review).International journal of oncology
Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic response.Frontiers in molecular biosciences
EsetismertetésRelapsed/refractory PBML complicated with failed platelet implantation and mixed infection after allo-HSCT: A case report.Medicine
EsetismertetésPrimary thyroid diffuse large B-cell lymphoma: a case report and focused review of the literature.Annals of hematology
CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital.Acta clinica Belgica
Clathrin recruitment and assembly of phosphorylated B cell receptor is impaired in human diffuse large B cell lymphoma.Molecular biology of the cell
EsetismertetésFulminant Synchronous Epstein-Barr Virus-Positive MALT Lymphoma and Diffuse Large B-Cell Lymphoma Monomorphic Post-Transplant Lymphoproliferative Disorder in a Child Following Heart Transplant: A Case Report.Pediatric transplantation
Persistent JC virus replication despite combined mirtazapine and mefloquine therapy: An autopsy case of progressive multifocal leukoencephalopathy with diffuse large B-cell lymphoma.Journal of neuropathology and experimental neurology
Confounder Identification in Diffuse Large B-Cell Lymphoma: Findings from an Expert Panel of German and Austrian Hematologists.Advances in therapy
A palmitoylation-related signature predicts prognosis and immune microenvironment features in diffuse large B-cell lymphoma.Frontiers in immunology
Pitfalls in the diagnosis of diffuse large B-cell lymphoma with flow cytometry.Acta clinica Belgica
EsetismertetésSequential targeted therapy for anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a case report.Frontiers in medicine
Clinical characteristics of 28 cases of primary adrenal lymphoma.Endocrine
EsetismertetésA case report and diagnostic-therapeutic analysis of de novo bilateral papillary thyroid carcinoma complicated with stage I a diffuse large B-cell lymphoma (ABC subtype, double-expressor).Frontiers in oncology
Megfigyeléses vizsgálatTissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma.Future oncology (London, England)
Integrative proteomic and metabolomic analysis reveals that ouabain inhibits DLBCL proliferation by reprogramming arginine-driven metabolic networks.Frontiers in pharmacology
A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.Blood